Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Down 57.3% in January

Arcadia Biosciences, Inc. (NASDAQ:RKDA) saw a significant drop in short interest in the month of January. As of January 15th, there was short interest totaling 9,188 shares, a drop of 57.3% from the December 31st total of 21,517 shares. Based on an average daily trading volume, of 29,690 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.7% of the company’s shares are short sold. Currently, 0.7% of the company’s shares are short sold. Based on an average daily trading volume, of 29,690 shares, the days-to-cover ratio is currently 0.3 days.

Arcadia Biosciences Price Performance

Shares of RKDA stock traded down $0.08 during trading on Thursday, reaching $2.10. The company had a trading volume of 49,487 shares, compared to its average volume of 30,715. The company has a market capitalization of $2.88 million, a PE ratio of 0.83 and a beta of 0.57. The firm’s 50 day simple moving average is $2.98 and its two-hundred day simple moving average is $3.61. Arcadia Biosciences has a one year low of $1.76 and a one year high of $6.71.

Arcadia Biosciences (NASDAQ:RKDA) last issued its quarterly earnings data on Friday, November 7th. The basic materials company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.54) by $1.16. The business had revenue of $1.30 million during the quarter, compared to analysts’ expectations of $1.90 million. Arcadia Biosciences had a negative net margin of 97.97% and a negative return on equity of 8.80%.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Arcadia Biosciences in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.

About Arcadia Biosciences

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.